LAVAL, Quebec, Feb. 6, 2018 /CNW/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)
("Valeant") will release its fourth-quarter and full-year 2017
financial results on Wednesday, Feb. 28,
2018. Valeant will host a conference call and live web cast
at 8:00 a.m. EST to discuss the
results and provide a business update. All materials will be made
available on the investor relations section of the Valeant web site
prior to the start of the call.
Conference Call
Details
|
Date:
|
Wednesday, Feb. 28,
2018
|
Time:
|
8:00 a.m.
EST
|
Webcast:
|
http://ir.valeant.com/events-and-presentations
|
Participant Event
Dial-in:
|
(844) 428-3520 (North
America)
|
|
(409) 767-8386
(International)
|
Participant
Passcode:
|
5287247
|
Replay
Dial-in:
|
(855) 859-2056 (North
America)
|
|
(404) 537-3406
(International)
|
Replay
Passcode:
|
5287247 (replay
available until Apr. 28, 2018)
|
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, gastrointestinal disorders,
eye health, neurology and branded generics. More information about
Valeant can be found at www.valeant.com.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@valeant.com
|
lainie.keller@valeant.com
|
(514)
856-3855
|
(908)
927-0617
|
(877) 281-6642 (toll
free)
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-fourth-quarter-and-full-year-2017-financial-results-on-february-28-300594219.html
SOURCE Valeant Pharmaceuticals International, Inc.